Investigator Site 709 — Birmingham, Alabama

Investigator Site 709 is a clinical research site located in Birmingham, Alabama, United States 35233-2110.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 709 has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Disease.

Sponsors: Vifor (International) Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 709?

Investigator Site 709 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 709 conducted?

Investigator Site 709 has 1 clinical trials on record. Their work covers Sickle Cell Disease.

Is Investigator Site 709 accredited by Crixeo Health?

Investigator Site 709 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 709?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.